Stage vs. Grade: What's the Difference?

This page explains the difference between cancer stage and cancer grade, and why your care team looks at both.

Stage and grade sound alike. Reports often list them right next to each other. But they answer two completely different questions. Stage asks: how far has this cancer spread? Grade asks: how abnormal do the cancer cells look, and how fast are they likely to grow? You need both to understand your full picture. Neither one alone tells the whole story.

Stage describes the extent of your cancer. It typically runs from stage 0 up through stage IV. Many cancers use the TNM system to determine stage:

• T stands for the size and extent of the main tumor.
• N stands for the number of nearby lymph nodes that contain cancer.
• M stands for whether the cancer has spread to other parts of the body.

These pieces combine into an overall stage. Stage answers a geographic question. Where is the cancer, and how far has it traveled from where it started?

Stage also comes in two forms. Clinical stage, written with a lowercase c as in cT2N0, is the estimate made before surgery from examination, imaging and biopsy. Pathological stage, written with a lowercase p as in pT2N1, is assigned after tissue has been removed and examined. They do not always match.

Grade is a different kind of assessment entirely. A pathologist (a doctor who studies tissue) looks at cancer cells under a microscope. They are compared to normal, healthy cells from that same tissue. Cells that still look fairly similar to normal cells are called low-grade, or well-differentiated. Cells that look very abnormal, disorganized, and unlike their tissue of origin are called high-grade. Doctors also call this poorly differentiated. Most tumors are graded on a scale of 1 to 4, where a higher number means the cells look more abnormal. Some cancers use a different grading system.

Grade is a behavioral question, not a geographic one. How aggressively is this specific cancer likely to grow and spread, based on what its cells look like right now?

The general scale runs:

• GX — grade cannot be assessed
• G1 — well differentiated, low grade
• G2 — moderately differentiated, intermediate grade
• G3 — poorly differentiated, high grade
• G4 — undifferentiated, high grade

As the National Cancer Institute puts it, the more normal the cells look, the less aggressive the cancer tends to be and the more slowly it tends to grow and spread.

Many cancers use their own grading systems instead of this generic scale. Prostate cancer uses the Gleason score and Grade Groups. Breast cancer commonly uses the Nottingham grade. Brain tumors, kidney cancers and sarcomas each have their own conventions. A grade 3 in one cancer does not mean the same thing as a grade 3 in another.

Two tumors can share the same stage. They can still behave very differently, because of grade. NCI says a high-grade cancer may grow and spread more quickly, so it may need more aggressive treatment right away. Your team decides what is right for you.

This is exactly why your oncologist looks at stage and grade together, along with other pathology details. Leaning on either one alone would not plan your treatment or explain your outlook well.

In some cancers grade is now built into the stage itself: modern breast and prostate staging combine anatomy with grade and biomarker results rather than using anatomy alone.

If only one appears, that is often normal. Grade is not reported for every cancer type, and a full pathological stage cannot exist until surgery has happened.

Grade and stage are not the whole picture. Ask your team what other test results they use, and how all of them fit your situation.

• What is my stage, and separately, what is my grade?
• How do my stage and grade together shape the treatment you're recommending?
• Does my grade suggest this cancer is likely to grow quickly or slowly?
• Are there other test results, beyond stage and grade, that matter for my specific plan?

• National Cancer Institute, Tumor Grade, accessed October 19, 2026
• National Cancer Institute — Cancer Staging
• National Cancer Institute, Pathology Reports Fact Sheet, accessed October 19, 2026